The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 03, 2023

Filed:

Mar. 12, 2019
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Sanjay Malhotra, Palo Alto, CA (US);

Vineet Kumar, Palo Alto, CA (US);

Dhanir Tailor, Palo Alto, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61P 35/00 (2006.01); C07D 215/14 (2006.01); C07D 491/048 (2006.01); C07D 491/153 (2006.01); C07D 221/06 (2006.01); C07D 221/18 (2006.01); A61K 31/4741 (2006.01); A61K 31/337 (2006.01); A61K 31/473 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4741 (2013.01); A61K 31/337 (2013.01); A61K 31/473 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07D 215/14 (2013.01); C07D 491/048 (2013.01); C07D 491/153 (2013.01);
Abstract

Compounds, compositions and methods are provided for the inhibition of GBP1. The subject inhibitor compounds can act by inhibiting GBP1 alone and/or GBP1: pro-survival kinase (e.g. serine/threonine-protein kinase pim-1 (PIM1)) interactions. Aspects of the subject methods include contacting a cellular sample with a GBP 1 inhibitor to inhibit the GBP 1 alone and/or GBP 1: PIM 1 interactions. Also provided are compositions and methods for treating cancer. In certain cases the cancer is resistant towards chemotherapy and radiation therapy.


Find Patent Forward Citations

Loading…